Removing Risk from Clinical Trial Management System (CTMS) Implementations
Date: Tuesday, November 28, 2017
Time: 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
Duration: 60 minutes
- Justin Hunt, Director, CTMS Implementation Services, Bioclinica
Beyond the challenges presented by the implementation process itself, enterprise CTMS systems require a significant investment of capital and manpower. The investment of both precious resources presents many opportunities for risk on the behalf of an organization choosing to purchase a CTMS.
This webinar will demonstrate how organizations can mitigate many of the common risks and challenges of implementing CTMS systems by starting with a small, limited implementation. A shared case study will highlight the benefits realized by a contract research organization (CRO) purchasing a CTMS utilizing this approach.
- Understand benefits of matching financial investment directly to initial need, limiting commitment until requirements are met
- How to complete CTMS implementation in a matter of weeks, not months
- Detail use of out-of-the-box, best-practices configuration capable of meeting current and future needs
Keywords: Clinical Trials, CTMS, CRO
Justin Hunt, Director, CTMS Implementation Services, Bioclinica
Justin Hunt is Director, CTMS Implementation Services at Bioclinica. He is responsible for the CTMS product at Bioclinica and leads the teams that implement OnPoint for Bioclinica customers and provide the post-implementation support. Prior to Bioclinica, Justin was Director of Operations & QA for TranSenda, which was acquired by Bioclinica in 2010, and has worked with the OnPoint product since its launch in 2005. He is based in Bellevue, WA, USA.
|THIS PROGRAM IS INTENDED FOR|
C-level and senior professionals responsible for clinical trials, including:
- Clinical Operations
- Clinical Outsourcing
- Data Management
- Project Management
- Strategic Planning
|XTALKS PARTNERS FOR THIS EVENT|
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment-retention solutions, and a post-approval research division.